NCT00957411 2025-11-24
CETUXICOL
Institut Curie
Phase 2 Completed
Clinical Trials
6 trialsNCT00104910 2014-12-31
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
GOG Foundation
Phase 1 Completed
NCT00101192 2014-03-17
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00086892 2014-02-14
Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Completed
NCT00392769 2012-09-06
Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00063401 2010-04-08
Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Eli Lilly and Company
Phase 2 Completed